logo
Plus   Neg
Share
Email

Axel Springer To Delist On April 6 From Frankfurt Stock Exchange - Quick Facts

German media holding company Axel Springer SE (AXELF.PK) announced Wednesday that the Frankfurt Stock Exchange has informed that its delisting application has been approved. The Axel Springer SE shares will be delisted from the regulated market of the Frankfurt Stock Exchange in accordance with the stock exchange regulations at the end of April 6, 2020.

Thereafter, the Axel Springer SE shares can no longer be traded on the Frankfurt Stock Exchange after being a listed company for a 35-year period.

Axel Springer SE assumes that the stock exchanges in Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart as well as Tradegate Exchange will end the inclusion of the Axel Springer SE shares in the open market likely in close temporal proximity with the delisting from the Frankfurt Stock Exchange.

Heralding a new phase of growth after departure from the stock market, Axel Springer said it will focus all its attention on its ambitious goal of becoming the world market leader in digital journalism and digital classifieds along with its strategic partner KKR (KKR). It added that the newly won freedom will be used to systematically implement and accelerate the strategy of growth and investments.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hyundai Motor has launched a new IONIQ brand dedicated to battery electric vehicles, as the automaker is accelerating its efforts to gain a share in the fast-growing global EV market. Under the IONIQ brand, Hyundai plans to introduce three new dedicated electric vehicle models over the next four years. Hyundai is South Korea's largest automaker. Amazon.com, Inc. is in talks with mall operator Simon Property Group, Inc. to use the abandoned anchor departmental stores of JC Penny and Sears at their malls as fulfillment centers, reports said. This is expected to help the e-commerce giant in boosting their last mile delivery, which is the last leg of the delivery process. The U.S. Food and Drug Administration announced the approval of Trevena Inc.'s Olinvyk (oliceridine), a new opioid for intravenous use in hospitals or other controlled clinical settings. Olinvyk is an opioid agonist to manage moderate to severe acute pain in adults, where the pain is severe enough to require an intravenous opioid and for whom alternative treatments are inadequate.
Follow RTT